The Defend Trade Secrets Act has been passed 87-0 in the US Senate. It would allow federal actions in response to the misappropriation of trade secrets, but it is not clear how big an impact it would have after some of the more controversial provisions were scaled back by a Senate committee and with the House of Representatives yet to vote on the bill
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The Delhi High Court declined to stop Dr. Reddy’s from manufacturing Novo Nordisk’s drug, but will continue to hear the Danish company’s injunction application